Leadership & Pay ·
Jade Biosciences, Inc. appointed Mark Eisner, M.D., M.P.H., to the Board of Directors as a Class I director and a…
JBIOJade Biosciences, Inc.
Jade Biosciences, Inc. appointed Mark Eisner, M.D., M.P.H., to the Board of Directors as a Class I director and a member of the Nominating and Corporate Governance Committee. Dr. Eisner previously held leadership roles at Vir Biotechnology, Inc., Sonoma Biotherapeutics, Inc., and FibroGen, Inc., and spent 11 years at Genentech, Inc. As part of his appointment, Dr. Eisner will receive an annual cash retainer and a stock option to purchase 47,675 shares of common stock. Jade Biosciences, Inc. is a biotechnology company focused on developing biological products for therapeutic use.